EHE RARE CANCER CHARITY (UK)
The EHE Rare Cancer Charity (UK) has three key objectives. Firstly we provide support to patients diagnosed with epithelioid haemangioendothelioma (EHE), a very rare form of vascular sarcoma. Secondly we are raising funds to support and fund research into EHE. Thirdly, we are working to raise awareness of EHE and to secure greater attention and improved care for people diagnosed with EHE.
Objects
1. THE RELIEF OF SICKNESS BY PROMOTING RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT, AND CURE OF CANCER INCLUDING BUT NOT LIMITED TO EPITHELIOID HEMANGIOENDOTHELIOMA AND PUBLISHING THE USEFUL RESULTS THEREOF,2. THE RELIEF OF PERSONS SUFFERING FROM CANCER BY IMPROVING METHODS OF TREATMENT.3. THE ADVANCEMENT OF EDUCATION IN THE CAUSES AND TREATMENT OF CANCER.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net surplus of £74,292 for the year ended 31 December 2024, with unrestricted funds totaling £242,027. The trustees confirmed that resources are adequate to continue operating, with no material uncertainties identified regarding going concern. Administrative costs were fully covered by a restricted donation from a single donor, ensuring all other incoming resources were available for charitable activities.
What the accounts disclose
Trustees
- HUGH LEONARDchair
- Dr Oliver Matthew Thomas Pearce
- JEFFERY IAN COLLINS
- KATE HOOPER
- Sally Jane Baker
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £133k | £54k |
| 31/12/2023 | £74k | £173k |
| 31/12/2022 | £107k | £164k |
| 31/12/2021 | £101k | £153k |
| 31/12/2020 | £53k | £133k |
Common questions
Is EHE RARE CANCER CHARITY (UK) financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net surplus of £74,292 for the year ended 31 December 2024, with unrestricted funds totaling £242,027. The trustees confirmed that resources are adequate to continue operating, with no material uncertainties identified regarding going concern. Administrative costs were fully covered by a restricted donation from a single donor, ensuring all other incoming resources were available for charitable activities. Its FY2024 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE BILLMEIR CHARITABLE TRUST | 2 | £19k |
| SANDRA CHARITABLE TRUST | 2 | £12k |
| PILKINGTON CHARITIES FUND | 2 | £11k |
| THE GROCERS' CHARITY | 2 | £9k |
| CBRE UK CHARITABLE TRUST | 2 | £3k |
| The Squire Patton Boggs Charitable Trust | 2 | £1k |
| THE PHILIP J MILTON AND COMPANY PLC CHARITABLE FOUNDATION | 1 | — |
| DENISE COATES FOUNDATION | 1 | £1.3m |
Charities like this
- CANCER 52
- SARCOMA UK
- THE EDWARD SHOWLER FOUNDATION
- CANCER ASSESSMENT RAPID EARLY SUPPORT
- THE ROYAL MARSDEN CANCER CHARITY
- THE EHLERS-DANLOS SUPPORT UK
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| EHE RARE CANCER CHARITY (UK) | £133k | — | 0 | unclear | — | no doubt |
| CANCER 52 | £363k | — | 0 | within | — | no doubt |
| SARCOMA UK | £4.6m | — | — | above | 26.0% | no doubt |
| THE EDWARD SHOWLER FOUNDATION | £144k | — | 0 | unclear | — | no doubt |
| CANCER ASSESSMENT RAPID EARLY SUPPORT | £246k | — | 0 | unclear | — | no doubt |
| THE ROYAL MARSDEN CANCER CHARITY | £34.0m | £149,102 | — | above | 27.0% | no doubt |